Gene · 5518
Papers1,733
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,733
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Studies in Cancer Epigenetics through a Sex and Gendered Lens: A Comprehensive Scoping Review. | Cancers (Basel) | 2023 | 37686484 | PubTator, text mining | PubMed |
| A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 37686291 | PubTator, text mining | PubMed |
| Inhibition of ATM-directed antiviral responses by HIV-1 Vif. | PLoS Pathog | 2023 | 37669285 | PubTator, text mining | PubMed |
| The Role of MicroRNAs in Development of Endometrial Cancer: A Literature Review. | J Reprod Infertil | 2023 | 37663424 | PubTator, text mining | PubMed |
| Editorial: Deciphering the etiology of rare genetic disorders associated with protein phosphatases. | Front Cell Dev Biol | 2023 | 37645249 | PubTator, text mining | PubMed |
| Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance. | Nat Commun | 2023 | 37644036 | PubTator, text mining | PubMed |
| Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis. | Biomolecules | 2023 | 37627318 | PubTator, text mining | PubMed |
| The fate of extra centrosomes in newly formed tetraploid cells: should I stay, or should I go? | Front Cell Dev Biol | 2023 | 37576603 | PubTator, text mining | PubMed |
| Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs. | Oncogene | 2023 | 37573406 | PubTator, text mining | PubMed |
| Quantitative proteomics and phosphoproteomics of PP2A-PPP2R5D variants reveal deregulation of RPS6 phosphorylation via converging signaling cascades. | J Biol Chem | 2023 | 37572851 | PubTator, text mining | PubMed |
| Clinicopathological characteristics and postoperative prognosis of patients with nuclear pedigree of esophageal squamous cell carcinoma. | Front Oncol | 2023 | 37538122 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes. | Acta Pharm Sin B | 2023 | 37521861 | PubTator, text mining | PubMed |
| Critical Overview of Serous Endometrial Intraepithelial Cancer Treatment: Systematic Review of Adjuvant Options. | Life (Basel) | 2023 | 37511804 | PubTator, text mining | PubMed |
| Circulating miRNAs as a Tool for Early Diagnosis of Endometrial Cancer-Implications for the Fertility-Sparing Process: Clinical, Biological, and Legal Aspects. | Int J Mol Sci | 2023 | 37511115 | PubTator, text mining | PubMed |
| Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities. | Biology (Basel) | 2023 | 37508437 | PubTator, text mining | PubMed |
| Heterogeneity in the gene regulatory landscape of leiomyosarcoma. | NAR Cancer | 2023 | 37492373 | PubTator, text mining | PubMed |
| Sequence variants contributing to dysregulated inflammatory responses across keratoconic cone surface in adolescent patients with keratoconus. | Front Immunol | 2023 | 37483635 | PubTator, text mining | PubMed |
| Evaluation of somatic mutations in cervicovaginal samples as a non-invasive method for the detection and molecular classification of endometrial cancer. | EBioMedicine | 2023 | 37480623 | PubTator, text mining | PubMed |
| Synchronous endometrial and ovarian cancer: A case report. | World J Clin Cases | 2023 | 37449219 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5518/papers?page=7